Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Richard Frisch

Orthopaedic Surgery Mt Pleasant, SC Medical Doctor

NPI 1053528752 CMS profile 228756

1625 Hospital Dr, Mt Pleasant, SC 29464

Open in the dashboard

General payments

$1,008,562

266 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,593 paid to institutions, not to them · program years 2020–2021

Through program year 2025, Richard Frisch of Mt Pleasant, SC is reported in the CMS Open Payments database as having received $1,008,562 across 266 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $2,593 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $151,738 32
2024 General $123,257 46
2023 General $160,371 37
2022 General $147,899 39
2021 General $143,613 52
2020 General $110,650 7
2019 General $171,034 53

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Richard Frisch
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Richard Frisch were reported at $151,738. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Richard Frisch Orthopaedic Surgery median Middle half National median
2019 $171,034 $644 $140–$2,844 $163
2020 $110,650 $312 $75–$1,860 $114
2021 $143,613 $520 $117–$2,495 $132
2022 $147,899 $598 $128–$2,731 $149
2023 $160,371 $461 $128–$2,264 $160
2024 $123,257 $497 $134–$2,475 $164
2025 $151,738 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $1,003,614 246 payments
  2. Alphatec Spine, Inc $3,888 7 payments
  3. Bioventus LLC $750 1 payment
  4. Orthofix Medical, Inc. $133 1 payment
  5. Abbott Laboratories $61 4 payments
  6. Spinal Simplicity, LLC $43 2 payments
  7. Boston Scientific Corporation $43 3 payments
  8. Providence Medical Technology, Inc. $16 1 payment
  9. Relievant Medsystems, Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $839,889 24 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $81,213 19 payments
  3. Consulting Fee $52,381 23 payments
  4. Travel and Lodging $30,854 80 payments
  5. Food and Beverage $4,225 120 payments
Products named General payments · program years 2019–2025
  1. QUARTEX Spine $327,811 11 payments
  2. QUARTEX Spine/Spine Surgery $252,291 7 payments
  3. QUARTEX Spine/Spine Surgery $139,036 4 payments
  4. QUARTEX Spine/Joint $121,061 5 payments
  5. RISE-L $17,289 4 payments
  6. CREO $12,148 4 payments
  7. RISE $11,695 4 payments
  8. ELSA ATP $11,172 4 payments
  9. ALTERA $10,312 3 payments
  10. MONUMENT $9,352 6 payments
  11. Other $78,370 205 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

35

Median for Orthopedic Surgery: 203

Drug cost

$273

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 20 $146
Celecoxib Generic 15 $127

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 72 billing codes

Paid by Medicare

$372,364

Of which drugs: $1,380

Medicare patients

765

Average age 74

Services billed

8,881

380 women, 385 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 29%
Ischemic heart disease 27%
Depression 24%
Chronic kidney disease 23%
Atrial fibrillation 16%
Cancer 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, gadobutrol, 0.1 ml A9585 Office 55 5,340 $1,365

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

266 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record